The DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat
Abstract
The effect of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on ethanol withdrawal symptoms was studied in chronically ethanol-fed rats. After a 4-day ethanol intoxication period the rats were given s.c. injections of dexmedetomidine (3, 10, or 30 micrograms/kg) or saline (control group) at 10, 16, 22, and 39 h after the last dose of ethanol. The severity of ethanol withdrawal symptoms (rigidity, tremor, irritability, hypoactivity) was rated up to 58 h, blind to the treatments. The results showed that dexmedetomidine at doses 10 and 30 micrograms/kg significantly diminished the severity of the ethanol withdrawal reaction as measured by the sum score of the three most specific withdrawal signs (rigidity, tremor, and irritability). Dexmedetomidine at 10 micrograms/kg was the most effective dose, especially in the latter half of the withdrawal period (23-58 h after last dose of ethanol). The results suggest that dexmedetomidine in the treatment of ethanol withdrawal symptoms should be further studied.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Induction of physical dependence upon ethanol and the associated behavioral changes in rats
Majchrowicz, E. (1975) · Psychopharmacologia · doi:10.1007/bf00429258 · Cited by 738
Effects of Intravenous Dexmedetomidine in Humans: II. Hemodynamic Changes
Bloor, B. C., Ward, D. S., Belleville, J. P., & Maze, M. (1992) · Anesthesiology · doi:10.1097/00000542-199212000-00014 · Cited by 729
Virtanen, R., Savola, J.-M., Saano, V., & Nyman, L. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90744-3 · Cited by 701
Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia.
Maze, M., & Tranquilli, W. J. (1991) · PubMed · Cited by 700
Effects of Intravenous Dexmedetomidine in Humans: I. Sedation, Ventilation, and Metabolic Rate
Belleville, J. P., Ward, D. S., Bloor, B. C., & Maze, M. (1992) · Anesthesiology · doi:10.1097/00000542-199212000-00013 · Cited by 556
Alpha-2 Adrenoceptor Agonists: Defining the Role in Clinical Anesthesia
Maze, M., & Tranquilli, W. (1991) · Anesthesiology · doi:10.1097/00000542-199103000-00029 · Cited by 537
A Hypnotic Response to Dexmedetomidine, an α2 Agonist, Is Mediated in the Locus Coerüleus in Rats
Correa-Sales, C., Rabin, B. C., & Maze, M. (1992) · Anesthesiology · doi:10.1097/00000542-199206000-00013 · Cited by 394
Hoffman, W. E., Kochs, E., Werner, C., Thomas, C., & Albrecht, R. F. (1991) · Anesthesiology · doi:10.1097/00000542-199108000-00022 · Cited by 280
SCHEININ, B., LINDGREN, L., RANDELL, T., SCHEININ, H., & SCHEININ, M. (1992) · British Journal of Anaesthesia · doi:10.1093/bja/68.2.126 · Cited by 271
Aantaa, R., Kanto, J., Scheinin, M., Kallio, A., & Scheinin, H. (1990) · Anesthesiology · doi:10.1097/00000542-199008000-00007 · Cited by 257
Cited by
Dexmedetomidine: Applications in pediatric critical care and pediatric anesthesiology
Tobias, J. D. (2007) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000257100.31779.41 · Cited by 367
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Subsequent studies have shown that a2-adrenergic agonists decrease somatic signs of alcohol withdrawal in animal models (Parale and Kulkarni, 1986; Riihioja et al., 1997), including responses that are associated with hyperkatifeia, such as the clonidine-induced blockade of anxiogenic-like effects…”
Backgroundα1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol
Walker, B. M., Rasmussen, D. D., Raskind, M. A., & Koob, G. F. (2008) · Alcohol · doi:10.1016/j.alcohol.2007.12.002 · Cited by 167
“Likewise, presynaptic a2-noradrenergic receptor agonists have been shown to reduce rigidity, tremor, and irritability associated with ethanol withdrawal (Riihioja et al., 1997a, 1997b).”
BackgroundInfluentialLogrip, M. L., Zorrilla, E. P., & Koob, G. F. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.007 · Cited by 130
“Thus, systemic administration of a2-AR agonists reduced somatic withdrawal signs for multiple drugs of abuse (Bruijnzeel et al., 2010; Riihioja et al., 1997; Tierney et al., 1988).”
BackgroundRole of α 2 -Agonists in the Treatment of Acute Alcohol Withdrawal
Muzyk, A. J., Fowler, J. A., Norwood, D. K., & Chilipko, A. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p575 · Cited by 107
Metadata
- Authors
- Riihioja, P., Jaatinen, P., Oksanen, H., Haapalinna, A., Heinonen, E., & Hervonen, A.
- Affiliations
- University of Tampere (FI)
- Tampere University Hospital (FI)
- Orion Corporation (Finland) (FI)
- Corresponding author
- Riihioja, Päivi
- Venue
- Alcohol
- Publisher
- Elsevier BV
- Published
- 1997-11
- Volume
- 14
- Issue
- 6
- Pages
- 537-544
- ISSN
- 0741-8329 (ISSN-L)
- OpenAlex
- W2032022636
- Cited by
- 40
- References
- 62
- Citations by year
- 2026: 1 · 2020: 1 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 1 · 2012: 1
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Alcohol (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tampereen Yliopisto
- Topics
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
- Keywords
- dexmedetomidine, ethanol withdrawal, alcohol withdrawal symptoms, alpha-2 adrenergic agonists, chronic ethanol feeding, tremor, irritability, rigidity, hypoactivity, dose-response relationship
- MeSH terms
- Adrenergic alpha-Agonists, Ethanol, Animals, Imidazoles, Injections, Subcutaneous, Kinetics, Male, Substance Withdrawal Syndrome, Rats, Wistar, Medetomidine, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat. https://app.cochat.ai/papers/10.1016/s0741-8329(97)00044-x
- The paper
- Riihioja, P., Jaatinen, P., Oksanen, H., Haapalinna, A., Heinonen, E., & Hervonen, A. (1997). Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat. Alcohol. https://doi.org/10.1016/s0741-8329(97)00044-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.